Pfizer's Centers
for Therapeutic Innovation (CTI) is
a unique joint drug discovery model focused on collaborating with leading
academic medical centers to translate and transform concepts into breakthroughs
that change patients' lives.
The CTI 2021 Call for Proposals (CFP) is
focused on identifying novel therapeutic targets with application
across Pfizer's core therapeutic areas: oncology, inflammation &
immunology, internal medicine and rare diseases.
Submission Process
· Develop
a 2-3 page non-confidential document outlining the scientific background and
research synopsis.
· Submit
your pre-proposal to Monash Innovation (innovation@monash.edu)
by 18 June 2021. The Pfizer
submission deadline is 28 June 2021.
Further information
For further information about submitting a
pre-proposal, please contact Chacko Joseph, Associate Commercialisation Manager, Monash
Innovation (chacko.joseph@monash.edu).
No comments:
Post a Comment